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Abstract
Background: There is strong evidence that anti- platelet therapy, ACE inhibitors, 
beta- blockers and statins are cost- effective in reducing subsequent cardiovascular 
disease (CVD) events in patients with atherosclerotic cardiovascular disease (ACVD). 
In some settings, only a low proportion of people have access to these medications, 
and even lower adhere to them. The current study explored and presents data on the 
causes of poor adherence to orthodox medication and motivations for alternative 
therapies in patients with established atherosclerotic cardiovascular disease (ACVD).
Methods: The study was conducted among city- dwelling adults with ACVD in Accra 
– Ghana's capital city. Eighteen interviews were conducted with patients with estab-
lished ACVD. A follow- up focus group discussion was conducted with some of them. 
The protocol was approved by two ethics review committees based in Ghana and 
in the United Kingdom. All participants were interviewed after informed consent. 
Analysis was done with the Nvivo qualitative data analysis software.
Results: We identified motivations for use of alternatives to orthodox therapies. 
These cover the five dimensions of adherence: social and economic, health- care sys-
tem, condition- related, therapy- related, and patient- related dimensions. Perceived 
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1  | INTRODUC TION
Every year, over 30 million people experience acute coronary 
event or stroke; one- quarter of these events occur in people with 
established atherosclerotic cardiovascular disease (ACVD).1 ACVD 
includes two major conditions: ischaemic heart disease (IHD) and 
cerebrovascular disease (mainly ischaemic stroke). These conditions 
accounted for a combined 15.2 million deaths worldwide in the year 
2016 and are the first and second causes of death worldwide.2 By 
2030, more than 23.3 million people are expected to die annually 
from cardiovascular diseases (CVDs).2
According to the World Health Organization (WHO), at least 
75% of deaths due to CVDs occur in low- and middle- income coun-
tries (LMICs).3 In these settings, the arterial events referred to 
above occur at an earlier age, affecting economically active popu-
lations and have a large economic impact.4 For instance, Agyemang 
et al showed that more than 50% of CVD- related deaths in Africa 
occur among persons 30- 69 years of age, which is 10 years or more 
below the equivalent group in the developed world.5 There are even 
bleaker projections that Africa's CVD burden will continue to rise 
and by 2020 it will double the burden in 1990.6
In Ghana, the WHO identified CVD as one of the top two 
causes of death after diarrhoeal disease.7 The probability of dying 
from CVD in Ghana for individuals between the ages 30 and 70 is 
20%.8 Trial evidence elsewhere has shown that in patients with 
established ACVD, medicines such as anti- platelet therapy, ACE 
inhibitors, beta- blockers and statins are cost- effective in reduc-
ing the risk of subsequent cardiovascular disease (CVD) events. 
Furthermore, the use of these medicines reduces the need for 
hospitalization, increase longevity and improve the health- related 
quality of life of the individual.9- 12 As a result, they are recom-
mended in clinical guidelines and included in the WHO Essential 
Medicines List (EML).13
Unfortunately, not all those who are in need of these medica-
tions take them. The PURE study, for instance, showed that in low- 
income countries only 1 in 5 patients with ACVD are receiving this 
group of cardiovascular drugs.14 Among those with access to these 
medications, suboptimal adherence is a major problem. There is 
abundant evidence that in LMICs adherence to these cardiovascular 
medications in patients with ACVD is poor. Kronish and Ye (2013) 
have shown that approximately 50% of patients with cardiovascular 
disease or its major risk factors have poor adherence to their 
prescribed medication.15
Many factors have been linked to non- adherence to prescribed 
orthodox medications by patients with ACVDs. First, health expec-
tations in the management and survival of ACVD patients are directly 
linked to the adherence to the conventional treatment regimen. 
There are other reasons – including patients’ stress and psycholog-
ical state, the availability, accessibility, affordability and perceived 
efficacy of alternatives which may affect adherence.16- 18 Patients’ 
perceptions of the disease (eg fatalistic perceptions, absence of 
symptoms) and the medications (eg fear of side- effects, confusion 
about multiple medications); patient– physician relationships; avail-
ability of family/social network support; and co- morbidities (eg de-
pression)19- 21 are other important factors. Available literature shows 
the tendency to focus on patient- related factors as the cause of 
medication non- adherence, to the relative neglect of factors such 
as those related to the health system. For this reason, the WHO re-
gards adherence as a multidimensional phenomenon determined by 
the interplay of at least five sets of factors, or ‘dimensions’ of which 
patient- related factors are just one determinant.22 We describe 
below some of these determinants/inter- related factors.
1.1 | Therapy- related factors
There are many therapy- related factors that affect adherence. Most 
notable are those related to the complexity of the medical regimen, 
poly- pharmacy and the adverse reactions engendered, previous 
treatment failures, frequent changes in treatment, the immediacy 
of beneficial effects, side- effects23- 27 and the availability of medical 
support to deal with them.
1.2 | Health- care system- related factors
Effective communication requires providing medication instruc-
tions at a level that the patient can understand. The ability of 
health- care providers to spend time communicating appropriately 
with a patient, their communication and interpersonal style have 
inability of an orthodox medication to provide immediate benefit is an important mo-
tivator for use of alternative forms of medication.
Conclusions: A multiplicity of factors precipitate non- adherence to orthodox thera-
pies. Perceived efficacy and easy access to local alternative therapies such as herbal 
and faith- based therapies are important motivators.
K E Y W O R D S
atherosclerotic cardiovascular disease, faith- based healing, Ghana, herbal therapies, Non- 
adherence, orthodox medication, qualitative research
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been found to be important in determining the level of adherence 
to medication.28,29 Several studies have shown that inadequate in-
formation and medical care coupled with poorly developed health 
services, non- existent health insurance plans and low doctor- to- 
patient ratio all impact negatively on medication adherence.22,30 
In a qualitative study exploring the barriers to medication adher-
ence among patients with uncontrolled diabetes, some patients 
indicated that seeing more than one care provider for the same 
issue could create confusion and complications in the care man-
agement plan.31
1.3 | Social and economic factors
Some factors reported to have a significant effect on adherence are 
poverty, illiteracy, low level of education, gender roles, unemploy-
ment, lack of effective social support networks, unstable living con-
ditions, and long distance from treatment centre.22,30,32,33 Health 
literacy is an acknowledged determinant of medication adher-
ence.34,35 Furthermore, societal norms in Ghana which breed suspi-
cion about science- based medication have been found to negatively 
affect the adherence to medication.25
1.4 | Condition- related factors
These factors refer to the demands the disease condition places 
on the patient. These may include severity of symptoms, severity 
of disability, and severity of disease.22 These influence patients’ risk 
perception and determine the level of importance the patient will 
attach to adhering to their medication regimen. It has been found for 
example that patients rated in poor health by their physicians were 
more likely to adhere to their medication.36
1.5 | Herbal and faith- based healing
For those in Ghana and similar African settings, high dependence on 
herbal and other non- orthodox alternatives is an important reason 
for non- adherence to prescribed therapies.18,37,38 The vast majority 
of the African people (80%), according to the WHO, rely on tradi-
tional medicine for their primary health- care need.39 Mander et al39 
note that many Africans do not consider traditional medicine an infe-
rior alternative to western medicine. To them, traditional medicine is 
desirable and necessary for treating a range of health problems that 
western medicine does not treat adequately.39 The Ghana Herbal 
Pharmacopoea (GHP) reveals that about 70% of Ghanaians depend 
on alternative health- care practices for their primary health- care 
needs.40 Several reports note that the use of herbal preparation for 
the management of ailments including ACVD is widespread in Ghana 
due to their perceived accessibility, affordability and perceived effi-
cacy as compared to orthodox medicine.41- 44 Others cite the inade-
quate number of health facilities coupled with the limited availability 
of trained personnel.45,46 There are also reports that herbal medi-
cine use is on the ascendency due to pressure from peers, family 
and relatives.25
In Ghana and other African countries, there is the notion that 
certain diseases are as a result of curses or angry deities and spells 
created by witchcraft. Certain illnesses are also seen as spiritual 
when they persist even after the patient has received treatment from 
a medical doctor or a herbalist.47 To cure these diseases therefore, 
there is the need to pray for God's forgiveness. Faith- based healers 
make claims of accessing the divine and providing a cure for various 
chronic ailments. The belief by some patients that spiritual healers 
have the power to cure disease conditions influences adherence 
to these medications. In a study to determine the consequence of 
religious beliefs on medication adherence among hypertensive pa-
tients in Ghana, it was observed that a lower likelihood of adhering 
to treatment was associated with high spiritual beliefs of patients.42
Given the high prevalence of people with established ACVD in 
LMICs and that improvement in adherence to cardiovascular medi-
cations has been associated with improved survival (~15%- 19% rel-
ative risk reduction of CVD events), any effort aimed at improving 
medication adherence has a great potential to improve population 
health.48 The purpose of this paper is to better understand how 
patients with established atherosclerotic cardiovascular disease 
(ACVD) in one middle income country, Ghana, adhere (or do not 
adhere) to necessary medication and causes of poor adherence to 
cardiovascular secondary prevention medications with a particular 
focus on the perceived efficacy of local alternative therapies.
2  | METHODS
2.1 | Study design
To explore factors associated with medication adherence in patients 
with established ACVD, a qualitative study design, deploying semi- 
structured interview and focus group discussions was conducted. 
This design was part of a larger study ( Global Txt2heart Pilot Study) 
which deployed a sequential mixed- methods design – a qualitative 
phase, followed with a quantitative phase. The qualitative phase 
identified key factors leading to poor adherence to CVD medica-
tions used for secondary prevention among the target population. 
The design, analysis and presentation of the data drive motivations 
from the WHO’s Five Interacting Dimensions of Adherence (see 
Figure 1).22
2.2 | Study settings
This study was conducted in the Greater Accra Region of Ghana 
among patients diagnosed of ACVD and receiving treatment at the 
Police Hospital, Accra. The Police Hospital provides health- care ser-
vices for members of the Ghana Police Service and their families as 
well as the general public, mostly patients within the national capital, 
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Accra. It also serves as a referral point to and from other health fa-
cilities. The pilot study was designed to be implemented in a typical 
health facility in Ghana's national capital – to generate data that fa-
cilitate scale- up in other facilities in the setting. Given resource con-
straints and other considerations (eg capacity to implement and test 
the planned mHealth intervention), the profile of the Police Hospital 
matched our definition of a typical health facility. Further consid-
eration to our choice was the fact that the scale- up phase of the in-
tervention will involve government, quasi- government and potential 
private facilities.
2.3 | Study respondents
Respondents were adults (>18 years old) of both genders, who owned 
a mobile phone and had at least 6 months of history of established 
ACVD defined as coronary artery disease (including non- primary 
coronary revascularizations), ischaemic stroke, peripheral artery 
disease and atherosclerotic aortic disease in whom anti- platelet, BP 
lowering medications and statins were recruited to partake in the 
study. Aware that, the intervention phase of the study would require 
ownership or access to a mobile phone – a platform via which pa-
tients/participants receive medication adherence intervention in the 
form of short messages services (SMS), ownership of a mobile phone 
served as one of the inclusion criteria. A maximum variation sample 
of 18 respondents selected (with consideration given to gender, age, 
location, medication adherence status and socio- economic status) 
participated in the semi- structured interviews. Six of the 18, who 
were purposively selected, agreed to participate in the focus group 
discussion. There was no prior relationship between the study par-
ticipants and the researchers (except co- author FB; a primary care 
physician for our study participants).
2.4 | Data collection
Two qualitative data collection methods – face- to- face semi- 
structured interviews and focus group discussions – were conducted 
by two experienced multilingual qualitative field researchers fluent 
in English and the two most commonly spoken Ghanaian languages 
in the study setting – Ga and Twi. Eighteen interviews were sched-
uled when ACVD patients visited the health facility for care. The 
duration for these interviews was between thirty and fifty minutes. 
A follow- up focus group discussion was conducted within the prem-
ises of the health facility. The focus group discussion lasted about an 
hour and thirty minutes. Data collection was preceded by obtaining 
consent from the medical facility to provide files on patients with 
ACVD diagnoses.
2.5 | Data analysis, reporting and quality assurance
Captured audio recordings of interviews and focus groups were 
translated directly to English (where applicable) and transcribed 
F I G U R E  1   Five dimensions of adherence
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verbatim by experts fluent in Ga or Twi and English languages. 
Themes were initially developed and transcripts and notes from the 
interviews were coded using Nvivo software (Version 11). Transcripts 
were coded by a data coder, adopting a mixed inductive and deduc-
tive approach using techniques drawn from grounded theory such as 
line by line analysis and the use of the constant comparative method. 
Co- authors AL, YF, EAA and GSA met to discuss major themes and 
issues that were not clear in the transcriptions. Data reporting was 
done according to the consolidated criteria for reporting qualitative 
research (COREQ).49
2.6 | Ethics considerations
Our study protocol obtained ethical approval from the Ghana 
Health Service Ethics Review Committee (Ref # GHS- ERC:06- 
09- 2016) and the London School of Hygiene and Tropical Medicine 
(Ref. # 12046). All interviews were conducted after informed 
consent.
3  | RESULTS
Our findings are organized around five main themes identified from 
the WHO’s Five Interacting Dimensions of Adherence.
3.1 | Patient- related dimension
Patient- related dimension of adherence refers to the resources, 
attitudes and the perception the patient has about the treatment 
regimen. The analysis identified ‘forgetfulness’ and ‘the availability 
of resources’ emerged as sub- themes.
3.1.1 | Forgetfulness
Some patients reported that they forgot to take their medication 
thus negatively impacting adherence. The following quotes describe 
examples of how patients forgot to take their medication because of 
tiredness or pre- occupation with chores:
‘Yes, at times when I’m busy doing some other chores, 
I do forget. Sometimes when I’m supposed to take the 
medication in the morning but I haven't eaten early I 
do forget to take...’ [IDI, female, 67 years].
3.1.2 | Resources
Some study participants reported that their inability to purchase 
their medication resulted in non- adherence. Below are quotes that 
describe how the lack of resources led to non- adherence which in 
some cases resulted in the worsening of disease symptoms:
‘Yes, it sometimes happens that for about two weeks 
I have not taken my drugs. At other times I can go for 
about one month without my medication because 
there is no money and it's within those times that the 
sugar level rises when I go for checkup’ [IDI, female 
57 years].
3.2 | Therapy- related dimension
The therapy- related dimension pertains to the difficulties patients 
face with regard to treatment benefits and side- effects. Perceived/
anticipated benefits of therapy, and actual or perceived side- effects 
are important sub- themes.
3.2.1 | Perceived/anticipated benefit of therapy
Some patients indicated that their medications were not pro-
viding the desired results – leading them to resort to the use 
of herbal medication. Patients interviewed had varied percep-
tions about the benefit of their treatment regimen. To some, 
any treatment regimen that does not bring instantaneous relief 
is deemed inefficacious or ineffective. Thus, most sought in-
stant healing of their conditions through herbal therapies (which 
are perceived to provide relief at a desired rate). Following are 
illustrative quotes:
‘I took the drugs for some time and stopped and 
went back to the herbal medicine. I drank about 10 
big bottles of the medicine so I realized that I had 
some form of relief in my bones. I couldn't lift up 
my hands and legs at first but as time went on I was 
able to lift my hands and legs and do everything on 
my own, so the Herbalist told me it's now okay so I 
should stop taking the medicine so till now I don't 
take any medicine. What the herbal medicine can do 
for me in a week, the orthodox does in a year’. [FGD, 
female, in her 50s].
3.2.2 | Actual or perceived side- effects
Quite a number of patients reported that the side- effects they ex-
perienced while on their medication negatively impacted their mo-
tivation to take their medication (Table 1). The quote below is an 
example of how patients were experiencing headaches and wanting 
to either stop taking the medication or moving to another one that 
does not have the side- effects:
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TA B L E  1   Motivations for use of alternative therapies and contributors to non- adherence to orthodox treatment in patients with 
established ACVD
Dimensions/





‘I started taking the orthodox medicines after going to the hospital, then my brother’s brother in- law 
visited one day and asked of my condition, after I had told him about my condition he recommended 
herbal medicine for me and offered to start buying it for me, if it works then I can start buying it on my 
own. When I started taking it I could taste garlic and other spices in the herbal solution. I even drank it 
whenever I was thirsty. After taking it for five days I started having tummy upsets and when I informed 
him he told me it was the way the drug works, it will wash my system so I continued till I had taken ten 
bottles. Before then I could not raise my legs and my arm but after taking the tenth bottle I could raise my 
arm and leg and could walk better, but I stopped after the tenth bottle’. [IDI, female 60 years].
‘For the hypertension drugs sometimes I don’t get it from the pharmacy at the police hospital. Sometimes 
I am given a package of the medication for 30 days so when the 30 days elapses then they may give me 
for two months or I may go and buy it. Sometimes they do tell me if it is finished I can come around and 
be given a new package but considering the transportation and the process I have to go through to get a 
folder I don’t go’. [IDI, Female 68 years]
‘………and if by then I don’t have money then I will skip a day or two and if I have money I will go and buy it’. 
[IDI, Male 59 years]
Unemployment ‘‘…okay to me a brother of mine told me that this thing it doesn’t happen on people by heart but maybe 
somebody has done it to you so when you go in spirit they can tell you the cause of your sickness and 
that’s what I am expecting, I’m very, very serious and its true too’’ [IDI, Male, 73 years]
‘When people visit me some give me money, so I put them together and then use that to buy my drugs 
because now I don’t work even the lady am with is not working so I depend on gifts from people to eat 
and buy my drugs’. [IDI, female 74 years]
Therapy- related Availability 
of effective 
treatment
‘I took the drugs for some time and stopped and went back to the herbal medicine. I drank about 10 big 
bottles of the medicine so I realized that I had some form of relief in my bones. I couldn’t lift up my hands 
and legs at first but as time went on I was able to lift my hands and legs and do everything on my own, 
so the Herbalist told me it’s now okay so I should stop taking the medicine so till now I don’t take any 
medicine. What herbal medicine does for me in week, the orthodox does in a year’ [FGD, Female in her 
50s]
‘Others even ask me how my condition got better, so I have even bought (herbal medication) for like 5 
people, all I have to do is to call the man and he will bring it’. [IDI, female in her 50s]
‘O yes I will go back to herbal. Just to cure’. [IDI, male 73 years]
Actual or perceived 
side- effects
‘I was not in agreement with what he proposed. Even though he is a doctor, I wasn’t in agreement with him. 
That medicine was good. He asked me to stop so he will give me a different medicine. The new one he 
gave me when I took it, I started having headache so I stopped taking it. It even led me to develop stroke. 
One day whiles lying on bed I experienced this severe headache’. [IDI, Male in his 60s]
‘I take all of them once a day, there is one I had to take twice but I take it once because of the side effects 
even though the doctor said twice a day I also take herbs because of the diabetes’ [IDI, male in his 60s]
‘Yes some of the drugs when I take them I begin to feel dizzy for some time and then it makes me sleep and 
also makes me feel kind of weak’ [IDI, female in her 50s]
Patient- related Resources ‘Yes, at times when I’m busy doing some other chores, I do forget. Sometimes when I’m supposed to take 
the medication in the morning but I haven’t eating early I do forget to take...’ [IDI, female, 67 years]
‘It’s only the financial that is only the challenge. At times you will need to do some test but when you check 
and the money is not going then it means you have to find a way of explaining to the doctor’ [IDI, female 
in her 60s]
‘Yes it happens sometimes for about two weeks and I have not taken my drugs other times too one month 
because there is no money and it’s within those times that the sugar level rises when I go for checkup’ 









‘The truth is with the herbal doctors, I was attending the herbal clinic at Dodowa and the way the doctor 
will treat you and have time to discuss with you it’s so nice. He will take his time with you and ask you 
questions and explained to you all that you need to know. He will tell you want you should eat. He even 
have a board with drawings of fruit on it telling you what to eat and what not to eat. That place he will 
tell you everything’ [FGD, Female 62 years]
‘Yes here at police hospital if you carry your health insurance card along they won’t give you the drugs so I 
have to go and buy it outside’ [IDI, female 61 years]
(Continues)
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‘The doctor told me that when I take the drug I will 
experience a slight headache while taking it. Later he 
asked me to stop taking it because when I take the 
medicine my head aches and I feel like dying so he 
asked me to stop’. [IDI, male, 63 years].
3.3 | Social and economic dimension
This dimension embodies such factors as family dysfunction (lack of 
family support) and cultural and lay beliefs about illness and treat-
ment etc The dimension also connects with a patient's acceptability 
and ability to seek alternative forms of treatment for their condi-
tion. We provide illustrative quotes pertaining to the sub- themes of 
‘family or social support/network’, and ‘cultural and lay beliefs about 
illness and treatment’.
3.3.1 | Family or social support or social network
Family and friends were found to be successful at introducing pa-
tients to herbal medication. The quotes following illustrate the 
contribution of family or peers to non- adherence to orthodox 
therapies:
‘My uncle is a herbalist and he knows much about 
the herbs so after he saw the scan results, he told 
them that I had stroke of the head. I was treated for 
5 days with the herbal medicines and truly on the 4th 
day, I was able to move from one point to the other. 
I went and took my bath and returned to the room. 
This herbal treatment continued till I started walking 
again’. [IDI, female, 37 years].
The data also revealed instances where family provided a support 
structure and facilitated adherence to medication. Below are quotes 
to support this:
‘My husband does that a lot when I finish eating. He 
will ask me to go for my drugs’. [IDI, female, 60 years].
‘With my drugs, my children also help me. They ask 
me if I have taken my drugs. Then I tell them, yes I 
have’. [IDI, female, 63 years].
3.3.2 | Cultural and lay beliefs about 
illness and treatment
In Ghana, socio- cultural factors underpin health- seeking behaviour 
and dictate the choice and utilization of treatment options for pa-
tients with chronic diseases. Culturally informed lay illness models 
strongly inform individual's attitudes. These can be so deeply held at 
an individual level that people may remain unaware of them – leaving 
them assumed shared knowledge and unquestioned. Patients with 
chronic diseases will visit the hospitals and take- home orthodox 
medicine but perceptions they may have on the aetiology and neces-
sary treatment for the condition may preclude them from adhering 
to orthodox medication. Cultural beliefs surround illnesses that do 
not resolve even after treatment from a medical doctor or a herb-
alist. Some illnesses are perceived to be spiritual and require that 
treatment is sought from faith healers. Some relatives of patients 
were of the view that their (chronic) condition had been brought 
upon them by spiritual forces and as such recourse was to be taken 
against those forces – as illustrated below.
‘Okay, a brother of mine told me that a condition 
like mine doesn't happen to people without spiritual 
undertones; maybe somebody has done it to you so 
when you go to the spirit they can tell you the cause 
of your sickness and that's what I am expecting’. [IDI, 
male, 73 years].
There was an instance where patients used orthodox medicine to 
treat their NCDs and then herbal medication to treat other conditions.
‘Before my present condition, there was a doctor by 
the Dodowa Road. When I consulted him, I took along 
all my medication with me. The place was a herbal 
hospital. When I went there, he asked me to con-
tinue taking my BP medications but not some other 
TA B L E  1   (Continued)
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‘‘I was told when you have stroke it can be treated forever you only keep taking your drugs and even if 
it will go it will take a very long time if I stop the drugs then I start feeling the pains when I start then it 
reduces, so if you get hypertension the treatment is not permanent’’[FGD, Male, 47 years]
‘I think it is all important (medication) because that’s her profession. I’m a lay man and I don’t know 
anything about medicine. I think it’s the best drugs that she has been prescribing for me’. [IDI, Male in 
his 50s]
‘So has there been an occasion where the doctor told you to take a particular amount of dosage in the 
morning and afternoon but you decided that the dosage wasn’t good for you so you altered the dosage by 
yourself?’ [Interviewer]
‘I don’t do that because I want to be healthy and be able to do things by myself’. [FGD, Male in his 60s]
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capsules given to me at the hospital. He said he will 
give me some other medicine that I will take in place 
of that. I even stopped going there almost about a 
year now but after taking the medication he has given 
to me I was okay. So, it was because of my stomach is-
sues that was why I went there but not because of the 
heart condition. After attending to me he told me I’m 
suffering from a heart condition so I should continue 
taking my medications’. [IDI, female, 68 years].
3.3.3 | Faith- based healing
Of note, our study participants acknowledge that both allopathic 
and herbal remedies have their limits. Some patients perceived their 
disease condition to be beyond either medical or herbal therapy. 
They therefore sought faith- based healing (prayers) which they re-
garded as superior to medical or herbal therapy. They note:
‘‘Life is like that. When you get sick and helpless, you 
have disgraced yourself. God being so good, I didn't 
come in a wheelchair. I have packed it somewhere in 
the garage. The Holy Spirit has helped me. He has en-
abled me to stand because when I lie down, what I 
hear is what I get up, get up.’ [IDI, female, 63 years].
3.4 | Health system- related dimension
The most prominent health system factor observed to affect medi-
cation adherence was relationship between the health- care provider 
and the patient. It was observed that patients will have liked their 
doctors to provide information about their condition. Others found 
that herbalist made time to explain their disease condition and an-
swer their queries. The below dialogue illustrates.
‘Does he (doctor) spend time to have discussion with 
you concerning your condition so that you will un-
derstand your condition very well and also explain 
all that you should do and not do to live healthy?’ 
[Interviewer].
‘No, even when you go to the hospital there are lot of 
people there so he has to be fast
with you so that other people will also have the turn 
to see him. Because the people are
many, the discussion will waste someone's time’. [IDI, 
female, 67 years].
Others found the herbal clinics were more receptive to their needs 
and that herbal doctors took time and answered their queries.
‘The truth is that, with the herbal doctors, I was at-
tending the herbal clinic at Dodowa and the way the 
doctor will treat you and have time to discuss with 
you it's so nice. He will take his time with you and ask 
you questions and explain to you all that you need 
to know. He will tell you want you should eat. He 
even had a board with drawings of fruit on it, telling 
you what to eat and what not to eat. He will tell you 
everything’. [FGD, female, 62 years].
3.5 | Condition- related dimension
Condition- related factors represent the particular illness- related 
demands faced by the patient such as the chronic nature of the con-
dition and the severity of symptoms of the condition. Our data re-
vealed that the chronic nature of the condition and the severity of 
symptoms acted as facilitators of medication adherence. Below are 
quotes to support this:
‘‘I was told when you have stroke it can be treated 
forever you only keep taking your drugs and even if it 
will go, it will take a very long time. if I stop the drugs 
then I start feeling the pains when I start then it re-
duces, so if you get hypertension the treatment is not 
permanent.’’ [FGD, male, 47 years].
‘It is helping. Example for the aspirin if I wake up and 
I forgot to take it then I start to feel dizzy but when I 
remember and I go and take it then I feel okay’. [IDI, 
Female, 67 years].
4  | DISCUSSION
Non- adherence to medication among patients with chronic ailments 
is a widespread practice in Ghana.25,47,50 This practice greatly affects 
health outcomes of such patients. In order to improve medication 
taking behaviour, it is important to understand the reasons for non- 
adherence. This paper presents data on our exploration of the causes 
of poor adherence to medication intake in patients with established 
atherosclerotic cardiovascular disease (ACVD). Organized according 
to the WHO five interacting dimensions of adherence, the current 
study shows that non- adherence is precipitated by a multi- factorial 
interplay of determinants – patient- related factors including the 
quest for curative measures, family support and social network, the 
health- care system and the treatment- related factors.
The WHO framework identifies the fact that cultural and lay 
beliefs of patients about illness are embedded in socio- cultural fac-
tors which underpin health- seeking behaviour and influence the 
choice and utilization of treatment options of patients of chronic 
diseases.22 Perception about the duration of the disease and aeti-
ology of the disease all affect health- seeking behaviour. In Africa, 
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illness perception goes beyond the Western biomedical approach. It 
is much more holistic involving not just the body but the mind and 
sometimes the supernatural.51 Healing practices also serve as a rep-
resentation of cultural beliefs, which influence health behaviours 
and serve as a framework for interpreting disease conditions.52 As 
stated in the previous paragraph, the current study identified that 
patients considered certain sicknesses as requiring spiritual atten-
tion for healing to take place.
Some patients with ACVD perceived herbal medication as pos-
sessing the ability to cure their condition and mostly preferred it 
over orthodox medication in some instances even in the face of 
adverse effects. As observed in the current study, episodes of diar-
rhoea experienced by a participant, which she attributed to the use of a 
herbal concoction, did not deter her from using it. Rationalization from 
her brother- in- law that such episodes of diarrhoea demonstrate the ef-
ficacy of the concoction, kept her going till the 10th bottle. In Ghana, 
this phenomenon has been noted by local sociologists, to have cul-
tural underpinnings where medications deemed efficacious, ‘have to 
first knock you off your feet and then bring you up’ (Professor Kodjo 
Senah, Personal Communications). This goes to show the strong cul-
tural attachments to the use of such medication. Our findings com-
pare with those of a study carried out in Ghana where hypertension 
was considered as not being a ‘hospital disease’ but a disease that re-
quired the use of herbal medicine to cure the condition.53 Elsewhere, 
traditional faith healers are sought for cures for diseases such as di-
abetes,54 hypertension55 and other complications of cardiovascular 
diseases such as stroke.56
In Ghana, diseases which persist after the patient has received 
treatment from a medical doctor or herbalist are described as spir-
itual.47,57 Such diseases are thought to require divine intervention 
resulting in non- adherence to orthodox therapies. The current study 
revealed that some patients preferred faith- based healing because 
of the promise of a cure to their health condition and the belief that 
the sickness had spiritual causations beyond medical treatment. The 
problem with faith- based healing is the conflict with medical care. It 
results in the belief that medication is unnecessary because ill health 
is an act of God and is uncontrollable except through divine inter-
vention. This was also observed in the current study where some 
patients were observed to have discontinued medication in favour 
of prayers.
The current study identified inadequate communication be-
tween patient and health- care professionals as a contributor to 
medication non- adherence. It was revealed that the sheer numbers 
of patients visiting the hospitals for medical care precluded health 
professionals from educating patients on their medication usage 
as well as side- effects and their health condition. In a similar study 
conducted to determine patients’ perceptions of medication adher-
ence, it was identified that a lack of education and patients’ fears 
of medication side- effects had the potential of adversely affecting 
medication adherence.58
This study also observed that, among ACVD patients, the use of 
herbal alternatives was not a primary choice. Most of them sought 
treatment in hospitals where they were given medication. The use of 
herbal alternatives came about when they could not obtain instant 
relief from the symptoms of their condition while taking the ortho-
dox medication. This finding compares favourably with that found in 
similar studies carried out in Ghana.25,50
Perceived medication inefficacy was another barrier to medi-
cation adherence. This finding was observed in another qualitative 
study which was carried out on TB patients in Ghana where the pa-
tients were observed to be impatient to take their medications as 
prescribed.59 The current study showed that some patients sought 
to augment the orthodox medication with herbal medication. Similar 
studies have also shown that doubt of treatment efficacy, distrust 
for medication and adverse effects were major causes of non- 
adherence to medication.60,61 This was also observed in the current 
study.
Our results are consistent with other studies reporting that so-
cial support directly affects adherence to orthodox medication. A 
study on healer shopping for diabetes in Ghana found that despite 
a preference for biomedical medication, the socio- economic im-
pacts of diabetes resulted in promoting a cure seeking behaviour in 
patients.50 The results of a similar study carried out in rural Ghana 
showed that socio- cultural and economic factors hinder social sup-
port and the patient's own social relations with family and or com-
munity members determine to an extent the social support he or she 
receives for their health condition.53
4.1 | Medical pluralism and adherence 
to orthodox therapies
As outlined earlier patients in Ghana have the opportunity to shop 
for healing from various systems/care providers – the allopathic 
health services delivery system, indigenous/traditional care delivery 
systems and faith- based providers. Referred to as medical plural-
ism62 or medical diversity,63 the use of multiple medical systems to 
address illness and wellness has been discussed, rather controver-
sially. The strongest criticism has come from critical medical anthro-
pology whose proponents stressed patterns of hierarchy and the 
dominance of biomedicine in the modern world, calling into ques-
tion the notion of ‘pluralism’ itself.64 Aside that, there is an ongoing 
debate about the contribution of indigenous/traditional healers, in 
chronic disease care in Africa.65 In Ghana, the practice of allopathy is 
often framed to compete with alternatives such as traditional/indig-
enous and faith- based remedies.66 Awah and Phillimore67 explored 
the tension between clinic- based demands for patients' ‘compliance’ 
with treatment guidelines, including repeated strictures against re-
sorting to ‘traditional’ medicine, and patients' own willingness to 
alternate between biomedicine and indigenous practitioners. Their 
work shows how traditional medicine can be something to work 
with and how it can improve situations, rather than regarding it as an 
ineffective opposition.
Critics of indigenous medicine point out its implications for ser-
vice uptake and adherence to allopathic care. In the current study, 
potential barrier to uptake and adherence to ACVDs medications 
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relate to the belief that traditional medicines have curative poten-
tial and spontaneity of action. We concur with de- Graft- Aikins66 on 
this subject. de- Graft- Aikins reported that the patients she engaged 
unfortunately set out to seek a ‘cure’ for an ‘incurable’ disease like 
diabetes. Similar claims are rife with other NCDs and in other African 
settings.65 On the basis of these, we recommend meaningful engage-
ment of stakeholders of this pluralistic health- care system (allopathic 
care providers, indigenous/alternative medicine care providers, policy 
makers, etc) so as to facilitate a nuanced understanding of the issues.
4.2 | Limitations of study
The study was conducted in one hospital in Accra the capital of 
Ghana and this could limit generalization of the findings due to the 
fact that medication adherence is a complex issue and could vary 
from setting to setting. Second, although the qualitative research as-
sistants were trained to handle courtesy bias or socially desirable re-
sponses on the part of all respondents, we are not able to wholly rule 
it out. Despite these limitations, this paper sheds light on important 
aspects of adherence to orthodox therapy in patients with ACVD in 
a cosmopolitan Ghanaian setting. These have the potential to impact 
practice, policy and further research.
4.3 | Implications for practice, policy and 
future research
Culture shapes health behaviours and serves as the lens by which 
experiences are interpreted and perceived.68 Understanding the 
cultural framework by which disease is interpreted is important in 
improving adherence to orthodox medication in ACVD patients. The 
WHO in the year 2002 identified the integral part traditional medicine 
plays in the health of Africans.69 The Ghana Herbal Pharmacopoeia 
(GHP) for example reported that due to various challenges with the 
orthodox health- care delivery system, at least 70% of Ghanaians de-
pend on alternative medicine for their health needs.40 Integrating 
traditional and orthodox medicine therefore expands the reach and 
enhances the result of community health care.70 In Ghana, attempts 
to integrate traditional and orthodox medicine have proved futile for 
reasons such as lack of education on the part of traditional medicine 
practitioners and the challenges with enforcing rules and ethics.71,72 
There are however opportunities for integration which can be con-
sidered. These could include enhancing medical doctors' sensitivity 
towards traditional healing and encouraging traditional healers to 
develop some collaborative work with medical doctors. There are 
various ways in which traditional healers can complement medi-
cal doctors, for example: acting as referral points, sending patients 
for biomedical treatment; discouraging traditional healers from any 
practices that may potentially harm the patients; and encouraging 
and monitoring adherence to the treatment regimen recommended 
by medical doctors.69
Health provider– patient communication is another area which 
requires attention. The study revealed that the high patient bur-
den on medical practitioners precluded effective communication 
with ACVD patients. Studies carried out to assess the feasibility of 
training of nurses in task shifting strategies for the management of 
chronic diseases like hypertension are a step in the right direction 
and their results should be implemented speedily.73
To conclude, this study identified widespread use of herbal ther-
apy (most of the time concomitantly with orthodox medication, and 
faith- based healing) by patients with established ACVDs. This is 
done in an attempt to treat and ‘cure’ their condition. As argued by 
Laar et al,74 until all stakeholders the pluralistic Ghanaian health- care 
system are made to understand that there is as yet no cure for such 
conditions, this phenomenon of seeking cures for ‘incurable’ health 
conditions will continue. These findings have important implications 
for orthodox medication adherence as far as the concomitant use of 
herbal preparations is concerned.
5  | PATIENT OR PUBLIC CONTRIBUTION
Clinicians and patients contributed to a co- development of a text 
message intervention to support patients with ACVD in Ghana 
adhere to treatment.
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